Name | NS398 |
---|---|
Synonyms |
MFCD00882995
Methanesulfonamide, N-[2-(cyclohexyloxy)-4-nitrophenyl]- N-(2-Cyclohexyloxy-4-nitro-phenyl)-; methanesulfonamide NS-398 Potassium Chloride N-[2-(Cyclohexyloxy)-4-nitrophenyl]methanesulfonamide |
Description | NS-398 is a non-steroidal an-inflammatory agent with analgesic and antipyretic effects, and selectively inhibits prostaglandin G/H synthase 2/cyclooxygenase 2 (COX-2) activity, with an IC50 of 3.8 μM, and has no effect on COX-1 at 100 μM. |
---|---|
Related Catalog | |
Target |
COX-2:3.8 μM (IC50) |
In Vitro | NS-398 is a non-steroidal an-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity, with an IC50 of 3.8 μM, and has no effect on COX-1 at 100 μM[1]. NS-398 weakly inhibits PG endoperoxide synthase activity from sheep seminal vesicle microsomes (IC50, 11 μM)[2]. |
In Vivo | NS-398 (0.5-10 mg/kg, p.o.) dose-dependently inhibits paw edema in rats, with an ED30 of 1.14 mg/kg, shows therapeutic effects on adjuvant arthritis (ED30, 4.69 mg/kg), exhibits dose-dependent analgesic activity (ED50, 1.65 mg/kg), and has antipyretic effect (ED50, 1.84 mg/kg) in rats. In mice, NS-398 suppresses writhing reactions induced by acetic acid with an ED50 of 8.2 mg/kg[2]. |
Animal Admin | Mice[2] Briefly, male ddy mice weighing about 30 g are used. The writhing syndrome is induced by injecting 0.75% of acetic acid, intraperitoneally. Ten minutes later, the number of writhings are counted for the next 10 min. NS-398 is administered orally 30 min prior to the injection. The analgesic effect is expressed as % of inhibition, compared with the vehicle-treated control[2]. Rats[2] Briefly, male Lewis rats weighing about 160 g are used. Arthritis is induced by injecting 0.1 mL of 0.7% Mycobacterium tubercu-losis-liquid paraffin into the left hind paw. On day 15, the rats are grouped according to the degree of secondary lesions in the right hind paw. NS-398 is administered orally once daily from days 15 to 18. Foot volume is measured on day 19. Relative edema volume (REV) is calculated for each animal[2]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 490.6±55.0 °C at 760 mmHg |
Melting Point | 139 °C |
Molecular Formula | C13H18N2O5S |
Molecular Weight | 314.357 |
Flash Point | 250.5±31.5 °C |
Exact Mass | 314.093628 |
PSA | 109.60000 |
LogP | 3.67 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.593 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | 22-24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 3824909990 |
~58% 123653-11-2 |
Literature: Su, Bin; Diaz-Cruz, Edgar S.; Landini, Serena; Brueggemeier, Robert W. Journal of Medicinal Chemistry, 2006 , vol. 49, # 4 p. 1413 - 1419 |
~% 123653-11-2 |
Literature: Su, Bin; Diaz-Cruz, Edgar S.; Landini, Serena; Brueggemeier, Robert W. Journal of Medicinal Chemistry, 2006 , vol. 49, # 4 p. 1413 - 1419 |
~% 123653-11-2 |
Literature: Su, Bin; Diaz-Cruz, Edgar S.; Landini, Serena; Brueggemeier, Robert W. Journal of Medicinal Chemistry, 2006 , vol. 49, # 4 p. 1413 - 1419 |
~% 123653-11-2 |
Literature: Wang, Min; Lacy, Gabrielle; Gao, Mingzhang; Miller, Kathy D.; Sledge, George W.; Zheng, Qi-Huang Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 2 p. 332 - 336 |
Precursor 4 | |
---|---|
DownStream 0 |
HS Code | 3824909990 |
---|